FDA offers guidance on drug development for ulcerative colitis, Crohn’s disease
Regulatory NewsMary Ellen Schneider
BiotechnologyClinical TrialsNorth AmericaPharmaceuticalsResearch, Design and DevelopmentRegulatory NewsMary Ellen SchneiderBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsResearch, Design and Development